Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Mar 15, 2022; 14(3): 664-677
Published online Mar 15, 2022. doi: 10.4251/wjgo.v14.i3.664
Published online Mar 15, 2022. doi: 10.4251/wjgo.v14.i3.664
Figure 5 Inhibition of O6-methylguanine-DNA methyltransferase contributes to the N-nitroso compound-induced cell malignant phenotype.
A and B: Cell anchorage-independent growth on soft agar and cell colony formation of N-methyl-N’-nitro-N-nitrosoguanidine/N-methyl-N-nitroso-urea-induced cells after O6-BG treatment; C: Cell anchorage-independent growth on soft agar of cells with O6-methylguanine-DNA methyltransferase (MGMT) knock-down; D: Knock-down efficiency of MGMT detected by Western blot; E and F: Cell anchorage-independent growth on soft agar and cell colony formation of MGMT overexpressing cells; G: The mRNA expression of MGMT in gastric endoscopic biopsy samples. The analyses were repeated three times, and the results are expressed as the mean ± SD. a,cP < 0.05. cP < 0.05, precancerous lesion and early cancer vs advanced cancer. EV: Empty vector; MGMT: MGMT overexpression; MGMT: O6-methylguanine-DNA methyltransferase.
- Citation: Chen YX, He LL, Xiang XP, Shen J, Qi HY. O6-methylguanine DNA methyltransferase is upregulated in malignant transformation of gastric epithelial cells via its gene promoter DNA hypomethylation. World J Gastrointest Oncol 2022; 14(3): 664-677
- URL: https://www.wjgnet.com/1948-5204/full/v14/i3/664.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i3.664